Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03678675 · ClinicalTrials.gov registry record · Phase 3
Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial
A Phase 3 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
NCT03678675 is a Phase 3 study that has completed, run by Tufts Medical Center. The registered enrollment target is 148 participants.
The verdict
NCT03678675, a Phase 3 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
Study Summary
To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.
Interventions
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2019-05-30 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03678675
The ClinicalTrials.gov registry entry for NCT03678675 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketorolac is the first listed.
NCT03678675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03678675 about?
NCT03678675 is a clinical study titled "Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial". To evaluate the efficacy of increased ketorolac in reducing opioid use after cesarean section.
What is the current status of trial NCT03678675?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2019-05-30. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03678675?
The interventions under investigation include: Ketorolac (DRUG).
Who is sponsoring clinical trial NCT03678675?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.